Wahlin S
Sweden
Research Article
Albumin Dialysis with Mars in Post-Hepatectomy Liver Failure (PHLF): Experiences from Two HPB Centers
Author(s): Gilg S, Escorsell A, Fernandez J, Garcia Valdecasas JC, Saraste L, Wahlin S, Nowak G, Stromberg C, Lundell L and Isaksson BGilg S, Escorsell A, Fernandez J, Garcia Valdecasas JC, Saraste L, Wahlin S, Nowak G, Stromberg C, Lundell L and Isaksson B
Aim: To study the impact of molecular adsorbent recirculating system (MARS) treatment on the outcome of patients with post-hepatectomy liver failure (PHLF). Patients and methods: Records of all patients treated with MARS due to PHLF between January 2003 and December 2013 at the intensive care units of Karolinska University Hospital (KH), Stockholm, Sweden, and Hospital Clinic (HC), Barcelona, Spain, were reviewed retrospectively. Results: Thirteen patients with PHLF were treated with MARS. Four patients suffered from PHLF secondary to serious post-operative complications and none of them survived. The remaining nine patients fulfilled the 50:50 Balzan criteria for PHLF. In these patients, MARS was commenced on post-operative day (POD) 3-21 (median 8) with a median of three cycles per treatment (range 2-6). In four patients who survived 90 days the treatment was started on POD 7-19 (me.. View More»
